Clinical Research Central Office
临床研究中心办公室
基本信息
- 批准号:7491898
- 负责人:
- 金额:$ 29.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2007
- 资助国家:美国
- 起止时间:2007-07-23 至 2012-03-31
- 项目状态:已结题
- 来源:
- 关键词:Biostatistics Shared ResourceCase Report FormClinical ResearchClosureControlled StudyDataData CollectionDatabasesDevelopmentEducationGrantInformaticsInstitutionMalignant NeoplasmsMissionModelingMonitorOncology GroupPatientsPoliciesPolicy DevelopmentsProceduresProtocols documentationReportingResearchResearch InfrastructureResearch PersonnelResource SharingSafetyServicesStandards of Weights and MeasuresSupervisionTrainingWisconsinWorkdevelopment policyexperiencehuman subjectmemberoncologyoutreachprogramsprotocol developmentquality assurance
项目摘要
The UWCCC Clinical Research Central Offices (CRCO) provides the infrastructure to support the clinical
research of UWCCC investigators. The CRCO is composed of experienced research staff and they are
facilitated in this support by the Biostatistics Shared Resource and the Cancer Informatics Shared Resource.
The services provided include:
Protocol review and implementation, which includes protocol identification, protocol review, protocol
activation, study closure, database management.
Human subjects committee coordination and oversight, which includes protocol activation and continuing
annual review.
Centralized patient tracking. .
Research policy development, coordination and implementation, which is developed and implemented
through the Program Manager Committee and the development of standard operating procedures.
Training coordination and implementation.
Education and corrective action facilitation.
Administrative oversight.
Additional services available to UWCCC investigator initiated studies include:
Protocol development and patient case report form development,
Data abstraction and final report tables.
The CRCO is under the supervision of the Associate Director (H Bailey) and Assistant Director for Clinical
Research (R. Arzoomanian), who have collaborated on clinical research for over 17 years.
UWCCC临床研究中心办公室(CRCO)提供支持临床研究的基础设施。
UWCCC研究人员的研究。CRCO由经验丰富的研究人员组成,他们
在生物统计学共享资源和癌症信息学共享资源的支持下,
所提供的服务包括:
方案审查和实施,包括方案识别、方案审查、方案
激活、研究关闭、数据库管理。
人类受试者委员会协调和监督,包括方案激活和持续
年度回顾。
集中患者跟踪。.
研究政策的制定、协调和执行,
通过项目经理委员会和标准操作程序的发展。
培训协调和执行。
促进教育和纠正行动。
行政监督。
UWCCC研究者发起的研究可获得的其他服务包括:
方案制定和患者病例报告表制定,
数据提取和最终报告表。
CRCO由副主任(H Bailey)和临床助理主任监督
研究(R. Arzoomanian),他们在临床研究方面合作超过17年。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
HOWARD H. BAILEY其他文献
HOWARD H. BAILEY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('HOWARD H. BAILEY', 18)}}的其他基金
Stress keratin 17 and CD4/8 ratio as prognostic markers in HIV-related anogenital squamous cell precancers and cancers (Biospecimens/Biocohort)
应激角蛋白 17 和 CD4/8 比率作为 HIV 相关肛门生殖器鳞状细胞癌前病变和癌症的预后标志物 (Biospecimens/Biocohort)
- 批准号:
10620051 - 财政年份:2022
- 资助金额:
$ 29.63万 - 项目类别:
Defining Tumor Microenvironment and Response to Immune Checkpoint Blockade in HIV-related Anogenital Squamous Cell Carcinomas (Immuno/microenvironment)
HIV 相关肛门生殖器鳞状细胞癌中肿瘤微环境的定义和对免疫检查点阻断的反应(免疫/微环境)
- 批准号:
10620043 - 财政年份:2022
- 资助金额:
$ 29.63万 - 项目类别:
Creating An Efficient Clinical Trial Build System via The Clinical Trials Rapid Activation Consortium (CTRAC)
通过临床试验快速激活联盟 (CTRAC) 创建高效的临床试验构建系统
- 批准号:
10227524 - 财政年份:2020
- 资助金额:
$ 29.63万 - 项目类别:
The MW Cancer Prevention Clinical Trials Network
MW 癌症预防临床试验网络
- 批准号:
10252839 - 财政年份:2020
- 资助金额:
$ 29.63万 - 项目类别:
The MW Cancer Prevention Clinical Trials Network
MW 癌症预防临床试验网络
- 批准号:
10475114 - 财政年份:2020
- 资助金额:
$ 29.63万 - 项目类别:
The MW Cancer Prevention Clinical Trials Network
MW 癌症预防临床试验网络
- 批准号:
10004825 - 财政年份:2020
- 资助金额:
$ 29.63万 - 项目类别: